학술논문
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference
Document Type
article
Author
Fabiana Gregucci; Sheila Spada; Mary Helen Barcellos-Hoff; Nina Bhardwaj; Charleen Chan Wah Hak; Alba Fiorentino; Chandan Guha; Monica L. Guzman; Kevin Harrington; Fernanda G. Herrera; Jamie Honeychurch; Theodore Hong; Lorea Iturri; Elisabeth Jaffee; Sana D. Karam; Simon R.V. Knott; Constantinos Koumenis; David Lyden; Ariel E. Marciscano; Alan Melcher; Michele Mondini; Anna Mondino; Zachary S. Morris; Sean Pitroda; Sergio A. Quezada; Laura Santambrogio; Stephen Shiao; John Stagg; Irma Telarovic; Robert Timmerman; Marie-Catherine Vozenin; Ralph Weichselbaum; James Welsh; Anna Wilkins; Chris Xu; Roberta Zappasodi; Weiping Zou; Alexandre Bobard; Sandra Demaria; Lorenzo Galluzzi; Eric Deutsch; Silvia C. Formenti
Source
OncoImmunology, Vol 12, Iss 1 (2023)
Subject
Language
English
ISSN
2162402X
2162-402X
2162-402X
Abstract
ABSTRACTFocal radiation therapy (RT) has attracted considerable attention as a combinatorial partner for immunotherapy (IT), largely reflecting a well-defined, predictable safety profile and at least some potential for immunostimulation. However, only a few RT-IT combinations have been tested successfully in patients with cancer, highlighting the urgent need for an improved understanding of the interaction between RT and IT in both preclinical and clinical scenarios. Every year since 2016, ImmunoRad gathers experts working at the interface between RT and IT to provide a forum for education and discussion, with the ultimate goal of fostering progress in the field at both preclinical and clinical levels. Here, we summarize the key concepts and findings presented at the Sixth Annual ImmunoRad conference.